The study aimed to evaluate whether frail patients—who are often directed toward minimally invasive procedures due to ...

PROWL is an open-label, retrospective, multi-center, U.S. registry of the Surmodics Pounce™ Thrombectomy Platform for the non-surgical removal of emboli and thrombi in the peripheral arterial ...

LAS VEGAS, Nov. 4, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, ...

A new trial suggests the optimal approach for basilar artery occlusion stroke may vary depending on whether the blockage ...

Transcatheter arterialization of the deep veins for chronic limb-threatening ischemia in no-option patients kept most ...

It is an exciting time in the field of carotid artery revascularization, with new data across a variety of therapies, innovative platforms emergin ...

Mesenteric ischemia results from insufficient blood flow to the intestines and has a high mortality rate, primarily due to delayed diagnosis. It is classified into acute (AMI) and chronic (CMI) forms, ...

TORONTO, Sept. 29, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that Health Canada has authorized the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a first-of-its ...

AngioSafe announced it has received FDA 510(k) clearance and CE marking for its Santreva-ATK endovascular revascularization catheter. San Jose, California-based AngioSafe designed the device for ...

The 2024 update of the ESC clinical practice guidelines on peripheral arterial disease (PAD) also includes aortic diseases, updating the 2017 and 2014 guidelines. This update has been endorsed by the ...